Product Information
MEMANTINE HCL 5 MG TABLET is a generic product labeled by Carlsbad Technology Inc., priced at $0.0793 per EA under NDC 61442019205. Its NADAC has been published 54 times since Sep 24, 2025.
FDA first approved this application on Apr 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Carlsbad Technology Inc.NDC
61442019205
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212947FDA Approved
4/3/2020
TE Code
AB
On Market Since
6/22/2025
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 5 MG TABLET has been published 54 times since Sep 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0793 per EA |
|---|---|
| All-time high | $0.0838 (May 13, 2026) |
| All-time low | $0.0788 (Jul 22, 2026) |
| 52-week high | $0.0838 |
| 52-week low | $0.0788 |
| Median price | $0.0809 |
| Average price | $0.0809 |
| Largest weekly change | -2.5% (Jun 17, 2026) |
| Weeks tracked | 54 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Carlsbad Technology Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 5 MG TABLET, manufactured by Carlsbad Technology Inc., is $0.0793 per EA (NDC 61442019205), effective Sep 30, 2026.
How has the price of MEMANTINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 5 MG TABLET has held within roughly two percent of its current level. It has been tracked across 54 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 5 MG TABLET?
Since Sep 24, 2025, the NADAC for MEMANTINE HCL 5 MG TABLET has ranged from a low of $0.0788 (Jul 22, 2026) to a high of $0.0838 (May 13, 2026), with a median of $0.0809 per EA.
Are there cheaper alternatives to MEMANTINE HCL 5 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MEMANTINE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MEMANTINE HCL 5 MG TABLET?
MEMANTINE HCL 5 MG TABLET (NDC 61442019205) is labeled by Carlsbad Technology Inc., and CMS classifies it as a generic product.